Biointestil® is an innovative and natural ingredient, patented and distributed exclusively by Fagron Italia, for the formulation of food supplements for the
well-being of the digestive function
Optimized and patented formulation
Biointestil® has been formulated with a patented technological process registered in Europe.
The patent covers:
- the use of essential oils or their individual components adsorbed on vegetable fiber in order to release the active substances of BIOintestil® in the colon.
- The mixing process that optimizes the powder, making it easier to manipulate and encapsulate.
Clinical study and dosage
Based on preclinical scientific studies, and a pilot clinical trial carried out on patients with Irritable Bowel Syndrome (IBS), currently being published, conducted at the Department of Clinical Medicine of the University of Bologna and the Department of Clinical Sciences and Experimental of the Spedali Civili di Brescia, BIOintestil® is able to positively modulate the intestinal microbiota, reduce abdominal swelling and regularize the intestine. The results of these studies suggest a maximum daily dosage of 1800 mg. The efficacy on the modulation of the intestinal microbiota and on the reduction of the clinical signs of colitis is observed already after 2 weeks starting from a dosage of 600 mg / day.
BIOintestil® can be used, according to the scientific literature and the indications of the regulatory bodies of European and non-European countries, in food supplements for intestinal well-being, as an adjuvant in the digestive process and in restoring correct intestinal functionality and regularity, helping to eliminate swelling , abdominal pain and flatulence.
BIOintestil® can be formulated with fibers and / or probiotics.